Marburg Virüsü Hastalığı

https://www.who.int/health-topics/marburg-virus-disease/#tab=tab_1

Bray M, Chertow D. Filoviruses. In: Clinical Virology, 4th, Richman DD, Whitley RJ, Hayden FG (Eds), ASM Press, 2017.

Emanuel J, Marzi A, Feldmann H. Filoviruses: Ecology, Molecular Biology, and Evolution. Adv Virus Res 2018; 100:189.

Glaze ER, Roy MJ, Dalrymple LW, Lanning LL. A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'. Comp Med 2015; 65:241.

Glaze ER, Roy MJ, Dalrymple LW, Lanning LL. A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'. Comp Med 2015; 65:241.

Towner JS, Khristova ML, Sealy TK, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497.

Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355:909.

Johnson ED, Johnson BK, Silverstein D, et al. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 1996; 11:101.

Ristanović ES, Kokoškov NS, Crozier I, et al. A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967. Microbiol Mol Biol Rev 2020; 84.

Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5:e1000536.

Adjemian J, Farnon EC, Tschioko F, et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J Infect Dis 2011; 204 Suppl 3:S796.

Gear JS, Cassel GA, Gear AJ, et al. Outbreake of Marburg virus disease in Johannesburg. Br Med J 1975; 4:489.

Timen A, Koopmans MP, Vossen AC, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis 2009; 15:1171.

Centers for Disease Control and Prevention (CDC). Imported case of Marburg hemorrhagic fever - Colorado, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:1377.

Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania. Centers for Disease Control and Prevention. Available at: https://emergency.cdc.gov/han/2023/han00489.asp?ACSTrackingID=USCDC_511-DM102954&ACSTrackingLabel=HAN%20489%20-%20General%20Public&deliveryName=USCDC_511-DM102954. (Accessed on April 10, 2023).

Amman BR, Jones ME, Sealy TK, et al. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 2015; 51:113.

Amman BR, Carroll SA, Reed ZD, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog 2012; 8:e1002877.

Martini GA. Marburg virus disease. Postgrad Med J 1973; 49:542.

Furuta Y, Gowen BB, Takahashi K, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 2013; 100:446.

Geisbert TW, Jaax NK. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct Pathol. 1998 Jan-Feb;22(1):3-17. doi: 10.3109/01913129809032253. PMID: 9491211.

Becker S, Spiess M, Klenk HD. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol. 1995 Feb;76 ( Pt 2):393-9. doi: 10.1099/0022-1317-76-2-393. PMID: 7844558.

Gedigk, P.; Bechtelsheimer, H.; Korb, G. Pathologic anatomy of the Marburg virus disease. In: Martini, GA.; Siegert, R., editors. Marburg Virus Disease. Springer–Verlag; NY, USA: 1971. p. 50-54.

Stille, W.; Boehle, E. Clinical course and prognosis of Marburg virus (‘green–monkey’) disease. In: Martini, GA.; Siegert, R., editors. Marburg Virus Disease. Springer–Verlag; NY, USA: 1971. p. 10-18

Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011; 204 Suppl 3:S810.

Glaze ER, Roy MJ, Dalrymple LW, Lanning LL. A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'. Comp Med 2015; 65:241.

Martini GA. Marburg virus disease. Postgrad Med J 1973; 49:542.

https://www.cdc.gov/vhf/marburg/diagnosis/index.html

Flyak AI, Ilinykh PA, Murin CD, et al. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell 2015; 160:893.

Cross RW, Bornholdt ZA, Prasad AN, et al. Combination therapy protects macaques against advanced Marburg virus disease. Nat Commun 2021; 12:1891.

Zhu W, Zhang Z, He S, et al. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model. Antiviral Res 2018; 151:39.

Bixler SL, Bocan TM, Wells J, et al. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Res 2018; 151:97.

Mulangu S, Dodd LE, Davey RT Jr, et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med 2019; 381:2293.

Warren TK, Wells J, Panchal RG, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014; 508:402.